Searched for
DRUG DEVICE COMBINATION
US stocks | Alphabet taps Intel to make three million in-house chips: ReportNvidia has not placed an order with Intel yet, but has been evaluating whether the company's technology can be used to make a processor tha...- Intel CEO unveils AI innovations and partnerships at mega tech event in TaiwanIntel unveiled new AI-focused technologies, strategic collaborations, and next-generation processors at Computex 2026. The company announce...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- How a 15-year-old boy gave millions of blind people the ability to readLouis Braille, a teenager, created a revolutionary dot-based reading system. This system, based on a six-dot cell, allows blind individuals...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Britney Spears alleges ex-bodyguard hacked her devices and Apple iCloud, threatens legal action; what do we know so farBritney Spears is threatening legal action against her former bodyguard, Thomas Bunbury, for allegedly hacking into her personal devices an...
- Strides Pharma's Chestnut Ridge unit in New York classified as voluntary action indicated by USFDAStrides Pharma Science announced its US subsidiary, Strides Pharma Inc, has received a Voluntary Action Indicated classification from the U...
- Alembic Pharmaceuticals gets USFDA nod for generic migraine treatment injectionAlembic Pharmaceuticals has achieved a pivotal milestone with the final green light from the US health authority for its generic Sumatripta...
- MedAlliance acquired by Cordis for $1.13 billionSwiss-based medical technology company MedAlliance has announced acquisition by Cordis for $1.13 billion. Cordis will play a pivotal role i...
- Stelis Biopharma receives establishment inspection report from USFDAThis follows the abbreviated quality system inspection technique drug pre-approval on-site inspection specifically conducted by the US Food...
- Harsh Vardhan launches website for information on clinical trial of CSIR ushered repurposed drugsThe Council for Scientific and Industrial Research (CSIR) has been exploring multiple combination clinical trials of antivirals with host-d...
- Union Health Ministry notifies medical equipment used on humans or animals as "drugs""In pursuance of sub-clause (iv) of clause (b) of section 3 of the Drugs and Cosmetics Act, 1940, the Central Government, after consultatio...
- Govt issues draft notification to bring all medical devices under single regulatory frameworkThe union health ministry has come out with the draft notification, making it mandatory for all the devices to get certified by the Central...
- Government to frame new rules on medical devices to draw investmentsIndia is the largest provider of generic drugs globally, with the Indian generics accounting for 20 per cent of global exports in terms of ...
- DoP earmarks Rs 300 crore for common facilities in medical parks"The Department has formulated a scheme for financing common facility centres in medical device park with an outlay of Rs 300 crore," DoP s...
- Government to develop six bulk drugs, medical devices parksThese parks will be established on the public private partnership (PPP) mode and the centre is in talks with various states for setting up ...
- Dr Reddy's Laboratories working on 18 new drug applications"As of March 31, 2015, we had 18 active products in our Proprietary Products development pipeline in various stages of development, the com...
- US approves handheld opioid antidote deviceA new handheld device that can quickly deliver a life-saving antidote for opioid overdose, including heroin has been approved by the US Foo...
- Sun Pharma: Strategic acquisitions to give drug firm a shot in the armGiven its past track record, investors can trust the company to go for strategically important acquisitions in its key markets.
- What Does Sun Pharma's September Quarter Performance Indicate?With Caraco resuming manufacturing at its facilities in Michigan, the company is likely to gradually recover any loss in revenues.
Load More
